- The global veterinary CRO and CDMO market is forecast to reach $19.61 billion by 2035, up from $7.38 billion in 2025.
- SNS Insider projects an 8.84% compound annual growth rate (CAGR) from 2026 through 2035.
- CDMO services represented approximately 85.5% of the market in 2025, while CRO services are expected to be the faster-growing service segment.
- Livestock accounted for about 63% of the market by animal type, although companion animal services are projected to see faster growth.
- North America was the largest regional market in 2025, while Asia-Pacific is expected to be the fastest-growing region.
- Readers can access a free sample of the veterinary CRO and CDMO market report or explore the complete report, segmentation and forecast.
The global market for veterinary contract research organization (CRO) and contract development and manufacturing organization (CDMO) services could nearly triple over the next decade as animal health companies increasingly outsource research, clinical development and manufacturing activities.
SNS Insider estimates the veterinary CRO and CDMO market was valued at $7.38 billion in 2025 and projects it will reach $19.61 billion by 2035. That represents a CAGR of 8.84% from 2026 to 2035.
The research firm attributes the anticipated growth to several factors, including animal disease prevalence, pet humanization, livestock production and increased outsourcing of drug development activities. Those outsourced functions can include preclinical and clinical testing, pharmacokinetics, regulatory support, formulation, process development and commercial-scale manufacturing.
CDMO services dominate veterinary outsourcing
CDMO services accounted for approximately 85.5% of the veterinary CRO and CDMO market in 2025, according to the report. SNS Insider said pharmaceutical manufacturing costs and complexity, along with the need to develop formulations for different species, are among the factors encouraging outsourcing.
CRO services represent a smaller portion of the market but are expected to be the faster-growing service category. The report associates that growth with animal disease prevalence and development of oncology and other specialty medicines for companion animals.
Pharmaceutical and biotechnology companies, meanwhile, represented approximately 58% of the market by end user in 2025. SNS Insider said outsourcing can help companies manage development costs and navigate clinical trials and regulatory approval processes.
Livestock leads, but companion animal segment gains ground
Livestock accounted for approximately 63% of the market by animal type in 2025, supported by demand for veterinary pharmaceuticals used in cattle, poultry, swine and other food-producing animals.
Companion animal services, however, are projected to record the highest growth rate among animal categories. The report links the trend to increasing pet humanization and associated investment in animal health.
Medicine and pharmaceutical applications represented the largest application segment in 2025. Biologics, vaccines and immunologics are expected to grow more rapidly, with SNS Insider pointing in particular to the potential expansion of mRNA vaccine technologies into veterinary medicine.
U.S. market projected to reach $5.48 billion
North America was the largest regional veterinary CRO and CDMO market in 2025. SNS Insider estimates the U.S. market at approximately $2.06 billion that year and forecasts it will reach roughly $5.48 billion by 2035, representing an 8.63% CAGR.
The report attributes U.S. growth in part to the concentration of animal health companies and continued outsourcing associated with biologics and mRNA vaccine pipelines.
Europe’s veterinary CRO and CDMO market was estimated at approximately $2.14 billion in 2025 and is projected to reach $4.37 billion by 2035. The report cites veterinary medicine regulations and the region’s established animal health outsourcing infrastructure as contributors to demand.
Asia-Pacific is projected to be the fastest-growing regional market during the forecast period, supported by animal health industry growth in China, livestock production in India and Japan’s veterinary pharmaceutical sector.
Additional veterinary market research
For readers interested in the underlying data and forecasts, SNS Insider provides a free sample of its Veterinary CRO and CDMO Market report, as well as the complete Veterinary CRO and CDMO Market report and forecast through 2035.
The company also lists related research on the veterinary clinical trials market, veterinary reference laboratory market, veterinary active pharmaceutical ingredients manufacturing market and veterinary medicine market.
Information sourced from the company’s press release.
